Journal of Coordination Chemistry · 2013 · 19 citations · 19 references
Natural SciencesBiochemistryChemistryInorganic ChemistryOrganic ChemistryOrganometallic ChemistryCoordination ChemistryInorganic SynthesisMetal-ligand BondingTransition Metal ChemistryTransition Metal ComplexesCytotoxicity AssaysMetalloid ComplexesPlatinum Compounds
Eight new platinum(II)/palladium(II) complexes with 4-toluenesulfonyl-L-amino acid dianion and diimine/diamine ligands, [Pd(en)(Tsile)]·H2O (1), [Pd(bipy)(Tsile)] (2), [Pd(bipy)(Tsthr)]·0.5H2O (3), [Pd(phen)(Tsile)]·0.5H2O (4), [Pd(phen)(Tsthr)]·H2O (5), [Pd(bqu)(Tsthr)]·1.5H2O (6), [Pt(en)(Tsser)] (7), and [Pt(en)(Tsphe)]·H2O (8), have been synthesized and characterized by elemental analyses, 1H NMR and mass spectrometry. The crystal structure of 7 has been determined by X-ray diffraction. Cytotoxicities were tested by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and sulforhodamine B assays. The complexes exert cytotoxicity against HL-60, Bel-7402, BGC-823, and KB cell lines with 4 having the best cytotoxicity against HL-60, Bel-7402, and BGC-823 cell lines; the compounds are less cytotoxic than cisplatin.
19
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial Wheate, Shonagh Walker, Gemma E. Craig et al. · Dalton Transactions · 2010 · 1.6K citations
Medicine, Oncology, Pharmacology +15
Cisplatin and platinum drugs at the molecular level (Review)
Teni Boulikas, Maria Vougiouka · Oncology Reports · 2003 · 728 citations
Medicine, Oncology, Pharmacology +14